Skip to main content
Science / Explained
SERIES: What Are PeptidesArticle 2 of 5
Peptides work like one key in one lock

Peptides work by fitting specific receptors and then triggering a cellular response. That receptor-fit model explains why one peptide can regulate hunger while another affects pain, immunity, or blood sugar.

Receptor fit starts the response

Cells carry receptors that respond to specific signals. When a peptide binds the receptor it fits, the cell changes activity and starts a downstream response.

Selectivity narrows side effects

Conventional drugs can behave like skeleton keys and act on unintended receptors. Peptide selectivity narrows the target surface, which can reduce off-target activity.

The lock-and-key model is simplified, but it remains practical: sequence shapes structure, structure determines receptor fit, and receptor fit drives effect.

Drug design extends the signal

Drug teams are not inventing new biology. They are extending known peptide signals so the same pathway can stay active long enough to be clinically useful.

Scientists are not inventing new biology. They are copying proven mechanisms.

OneMoreThing

Tetrodotoxin, from pufferfish, blocks one specific sodium channel on nerve cells.One lock.The nerve cannot fire.Muscles cannot contract.The prey is paralyzed.

But the pufferfish itself has the same sodium channel.Evolution modified exactly one amino acid in the pufferfish's version so the toxin cannot bind its own lock.The pufferfish carries a weapon that fits every lock except its own.One amino acid.The difference between predator and prey.

← Previous
Peptides are the body's messenger molecules
Next →
Twenty amino acids build every peptide the body makes
References5 sources

How to read these sources

This article uses primary sources and reviews to separate mechanism, human evidence, and context.

MechanismCell and pathway logic
ReviewExpert synthesis
Show 3 more source types
Official LabelRegulator documents
Human TrialStudies in people
Public UpdateNews or announcements
  1. Mechanism

    Journal of Biological Chemistry

    American Society for Biochemistry and Molecular Biology

    Lei, S., et al. · 2018 Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism. Read source

    Used Here For

    Showing that receptor structure changes how peptide signals behave.

    Good For

    Mechanism, pathway logic, and why receptor "fit" can matter.

    Not For

    Proving patient outcomes or comparing treatments in people.

    J Biol Chem 293(24):9370-9387
    DOI 10.1074/jbc.RA118.003278
  2. Review

    Physiological Reviews

    American Physiological Society

    Holst, J.J. · 2007 The physiology of glucagon-like peptide 1. Read source

    Used Here For

    Grounding how the GLP-1 signal is received and acted on in established physiology.

    Good For

    Understanding GLP-1 biology and how its receptor signaling works.

    Not For

    Dosing guidance, treatment comparisons, or weight-loss outcome claims.

    Physiol Rev 87(4):1409-1439
    PMID 17928588DOI 10.1152/physrev.00034.2006
  3. Review

    Drug Discovery Today

    Elsevier

    Fosgerau, K., & Hoffmann, T. · 2015 Peptide therapeutics: current status and future directions. Read source

    Used Here For

    Framing peptides as a therapeutic class built on receptor selectivity.

    Good For

    An overview of how peptide drugs are designed and used.

    Not For

    Specific product claims, dosing, or individual outcome data.

    Drug Discov Today 20(1):122-128
    PMID 25450771DOI 10.1016/j.drudis.2014.10.003
  4. Review

    Chemical Biology & Drug Design

    Wiley

    Craik, D.J., Fairlie, D.P., Liras, S., & Price, D. · 2013 The future of peptide-based drugs. Read source

    Used Here For

    Supporting why receptor-specific fit makes peptides useful as medicines.

    Good For

    Understanding the design advantages and limits of peptide drugs.

    Not For

    Comparing named treatments or proving clinical results.

    Chem Biol Drug Des 81(1):136-147
    PMID 23253135DOI 10.1111/cbdd.12055
  5. ReviewSpringer Nature

    Muttenthaler, M., et al. · 2021 Trends in peptide drug discovery. Read source

    Used Here For

    Placing the receptor-fit model in the broader arc of peptide drug development.

    Good For

    A current map of where peptide therapeutics are heading.

    Not For

    Individual product guidance, dosing, or head-to-head comparisons.

    Nat Rev Drug Discov 20(4):309-325
    PMID 33536635